Ocrevus Liver Damage: Swissmedic Update on Ocrelizumab Risks
On January 28, 2026, Swissmedic released a statement regarding Ocrevus (ocrelizumab), a medication used to treat multiple sclerosis. The update…
Switzerland
Switzerland updates on medical device regulation and quality.
156 articles
156 articles in Switzerland
Europe
Europe
Swissmedic Approves Extension of Therapeutic Indication for Hepcludex
On January 27, 2026, Swissmedic announced the extension of the therapeutic indication for Hepcludex, a medication used to treat a…
Europe
Swissmedic Expands Indication for Amvuttra
Published January 26, 2026 The Swiss Agency for Therapeutic Products (Swissmedic) announced an extension of the therapeutic indication for Amvuttra,…
Europe
Swissmedic Introduces New Requirements for Integral Combination Products
On January 21, 2026, Swissmedic announced new requirements for the authorization of medicinal products with integral medical device components, also…
Europe
Swissmedic Batch Recall of Risperidon-Mepha LA Injection
What Changed? As of January 22, 2026, Swissmedic announced a batch recall of Risperidon-Mepha LA Pulver und Lösungsmittel zur Herstellung…
Europe
Breaking Swissmedic News: Critical Quality Issue with Arixtra® Fondaparinux Sodium Prefilled Syringe Needles
Europe
Swissmedic Approves Redundancy Plan for Headcount Reduction
Swissmedic has finalized a redundancy scheme in response to an announced staff reduction at the organization. The plan has been…
Europe
Swissmedic Expands Approval for Calquence® Therapeutic Indication
On January 15, 2026, Swissmedic officially approved an extension of the therapeutic indication for Calquence®, marking a significant regulatory development…
Europe
Temporary Authorization for Abilify i.m. Injection Solution Due to Supply Shortage
Swissmedic, Switzerland’s authority for therapeutic products, has announced the temporary authorization for the distribution of Abilify i.m. injection solution (7.5mg/ml)…
Europe
Swissmedic Confirms New Blood Donation Guidelines to Address vCJD Concerns
On February 1, 2026, new blood donation criteria from Swiss Transfusion SRC will take effect, marking a critical update in…
Europe
Swissmedic welcomes Vincenza Trivigno as new Executive Director
On January 12, 2026, Swissmedic, the Swiss agency responsible for the authorization and monitoring of therapeutic products, announced a significant…
Europe
Streamline Medical Device Registration with Swissmedic: Free Webinar Highlights swissdamed Tools
Swissmedic, Switzerland’s national agency for therapeutic products, is offering a complimentary webinar on May 28, 2026. This online session will…
Loading more articles…